Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17380 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Anaïs Clara Terol-Úbeda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Farmacología. Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Rats, Wistar, Norepinephrine, Receptors, Serotonin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Salamanca.
Abstract (Originalsprache)
Background and Purpose In male rats, the serotonergic system modulates sympathetic outflow at vascular levels, causing sympatho‐inhibition and sympatho‐excitation, mainly via 5‐HT 1D/1A and 5‐HT 3 receptors, respectively. However, sex influence on vascular serotonergic regulation has not yet been elucidated. This study aimed to analyse the 5‐HT sympatho‐modulatory role in female rats, characterising the 5‐HT receptors involved. Experimental Approach Female Wistar (14‐ to 16‐week‐old) rats were prepared for sympathetic stimulation. Mean blood pressure (MBP) and heart rate (HR) were continuously measured. Vasopressor responses were obtained by electrical stimulation of the sympathetic outflow (0.1–5 Hz) or i.v. noradrenaline (0.01–0.5 μg·kg −1 ). 5‐HT‐related drug effects on adrenergic system were determined. Age‐matched male rats were used as control. Key Results Basal MBP in females was lower than in male rats, whereas electrical‐induced increases in MBP were similar. In females, 5‐HT exerted a dose‐dependent inhibition on the sympathetic‐evoked vasoconstrictions, that was reproduced by some agonists; 5‐CT (5‐HT 1/5/7 ) and L‐694,247 (5‐HT 1D ), whereas the selective 5‐HT 2A/2B/2C ( α ‐methyl‐5‐HT) and 5‐HT 3 agonist (1‐PBG) increased the electrically‐produced vasopressor responses. None of the other drugs tested (targeting 5‐HT 1A/1B/1F , 5‐HT 2B/2C , 5‐HT 4 , 5‐HT 5A or 5‐HT 7 ) modified these vasoconstrictions. Only 1‐PBG (5‐HT 3 ) modified the vasoconstrictions induced by exogenous noradrenaline. Conclusions and Implications In female rats, vascular serotonergic sympatholytic effects are due to prejunctional 5‐HT 1D receptor activation, whereas pre and/or postjunctional 5‐HT 3 and prejunctional 5‐HT 2A receptor activation is involved in the potentiating effect of vascular sympathetic neurotransmission. These findings may open novel sex‐differential therapeutic strategies for treating cardiovascular conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Farmacología. Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain.
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
ORCID-Profile: Mónica García-Domingo
Förderung
- University of Salamanca
Zitieren
APA
Terol-Úbeda, A. C., Fernández-González, J. F., Roldán-Hernández, C. A., Martín, M. L., Morán, A., García-Domingo, M., & García-Pedraza, J. Á. (2025). Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.17380
Vancouver
Terol-Úbeda AC, Fernández-González JF, Roldán-Hernández CA, Martín ML, Morán A, García-Domingo M, et al. Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats. British Journal of Pharmacology. 2025. doi:10.1111/bph.17380
BibTeX
@article{Terolbeda2025,
author = {Terol-Úbeda, Anaïs Clara and Fernández-González, Juan Francisco and Roldán-Hernández, Carlos Andrés and Martín, María Luisa and Morán, Asunción and García-Domingo, Mónica and García-Pedraza, José Ángel},
title = {Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17380}
}
EUVIMED